Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131850) titled 'A comparative study of remimazolam benzenesulfonate and propofol for sedation in gastrointestinal endoscopy in the elderly' on Sept. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: He Kou District People's Hospital,Dongying City
Condition:
Gastrointestinal endoscopy
Intervention:
Remimazolam group:Intravenous injection of remimazolam (0.15-0.3 mg/kg) combined with 0.05 mg of fentanyl
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-07
Target Sample Size: Remimazolam group:79;Propofol group:79;
Countries of Recruitment:
China
To know more...